Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST

Updated Interim Results for the Six Months Ended 30 June 2023


NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough...

Related Keywords

United States ,United Kingdom ,London ,City Of ,Bermuda ,American ,Tanuja Chitnis ,Matthew Davis ,Monte Carlo ,Gabriele Cerrone ,Saef Izzy ,Williama Haseltine ,Williama Clementi ,Paul Spencer ,Irina Koffler ,Howard Weiner ,Tiziana Life Sciences ,Lifesci Advisors ,Pharma Ltd ,International Accounting Standards Board ,International Conference On Alzheimer ,Tiziana Life Sciences Ltda Bermudan ,Investment In Related Party ,Proceedings Of The National Academy Sciences ,Tiziana Life Sciences Ltd ,Ann Romney Center ,American Academy Of Neurology ,Investment In Accustem Sciences Inc ,Clinical Program Updates ,London Stock Exchange ,Rasna Therapeutics Inc ,Drug Administration ,Planwise Ltd ,Group Is Planwise Ltd ,Business Development ,Research In Multiple Sclerosis ,Capital Market Exchange ,Accustem Sciences Inc ,International Financial Reporting Standards ,Nasdaq ,European Committee For Treatment ,Updated Interim Results ,Six Months Ended ,Life Sciences ,Executive Chairman ,Chief Executive Officer ,National Academy ,Expanded Access ,Expanded Disability Status Scale ,Brigham Women ,Mass General Brigham Healthcare System ,International Conference ,Related Neurological Disorders ,Neurologic Diseases ,Assistant Professor ,Harvard Medical School ,American Academy ,Positron Emission Tomography ,Year Operational ,Chief Medical Officer ,Chief Operating Officer ,Acting Chief Executive Officer ,Chief Development Officer ,Clinical Program ,Investigational New Drug ,Modified Fatigue Impact Scale ,Secondary Progressive Multiple Sclerosis ,European Committee ,Multiple Sclerosis ,Device Training ,Half Financial ,Interim Report ,Annual Report ,Investor Relations ,Sci Advisors ,Related Party ,Treasury Shares ,Interim Financial ,Life Sciences Ltd ,Clarendon House ,Tiziana Life Sciences Limited ,Market Exchange ,Intangible Assets ,Convertible Loan Notes ,Share Option Plan ,Option Plan ,Incentive Plan ,Therapeutics Inc ,Shared Services ,Sciences Inc ,Planwise Group ,Markets ,